Quality key factors
Factor
Value
Sales Growth (5y)
10.75%
EBIT Growth (5y)
-15.65%
EBIT to Interest (avg)
16.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0
Tax Ratio
46.24%
Dividend Payout Ratio
54.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.77%
ROE (avg)
17.17%
Valuation Key Factors 
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.92
EV to EBIT
1.37
EV to EBITDA
1.24
EV to Capital Employed
0.82
EV to Sales
0.03
PEG Ratio
0.02
Dividend Yield
5.62%
ROCE (Latest)
59.52%
ROE (Latest)
16.46%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Farmaceutica Remedia SA
Net Sales - Quarterly
Highest at RON 146 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (RON MM)
Operating Profit (PBDIT) - Quarterly
Highest at RON 4 MM.
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (RON MM)
Operating Profit Margin - Quarterly
Highest at 2.59%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales (RON MM)
Here's what is not working for Farmaceutica Remedia SA
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at RON 1 MM.
in the last five periodsMOJO Watch
Near term PBT trend is negative
PBT less Other Income (RON MM)
Profit After Tax (PAT) - Quarterly
Lowest at RON 1 MM.
in the last five periodsMOJO Watch
Near term PAT trend is negative
PAT (RON MM)
Earnings per Share (EPS) - Quarterly
Lowest at RON 0.01
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (RON)






